Comparison of Mycophenolate Mofetil and Cyclophosphamide for Active Takayasu's Arteritis

PHASE3CompletedINTERVENTIONAL
Enrollment

138

Participants

Timeline

Start Date

March 16, 2017

Primary Completion Date

November 11, 2022

Study Completion Date

November 11, 2022

Conditions
Takayasu Arteritis
Interventions
DRUG

MMF

Patients were treated with Glucocorticoids combined with methotrexate and mycophenolate mofetil

DRUG

CYC

Patients were treated with Glucocorticoids and cyclophosphamide sequentially with azathioprine

DRUG

Glucocorticoids

Patients in the experimental group and comparator group were treated with Glucocorticoids and then gradually tapered

DRUG

MTX

Patients in the experimental group are treated with Glucocorticoids combined with MTX and MMF

DRUG

AZA

Patients in the active comparator group were treated with Glucocorticoids combined with CYC followed by AZA

Trial Locations (7)

100020

Beijing Chaoyang Hospital, Beijing

100032

Peking Union Medical College Hospital, Beijing

100053

Beijing Xuanwu Hospital, Beijing

300052

General Hospital of Tianjing Medical University, Tianjin

710032

Xijing Hospital, Xian

050051

Hebei Provincial Hospital, Shijiazhuang

010050

the Affiliated Hospital of Inner Mongolia Medical University, Hohhot

All Listed Sponsors
collaborator

Peking Union Medical College Hospital

OTHER

lead

Chinese SLE Treatment And Research Group

OTHER

NCT03096275 - Comparison of Mycophenolate Mofetil and Cyclophosphamide for Active Takayasu's Arteritis | Biotech Hunter | Biotech Hunter